Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

CDX1 is a transcription factor that plays a key role in intestinal development and differentiation. However, the downstream targets of CDX1 are less well defined than those of its close homologue, CDX2. We report here the identification of downstream targets of CDX1 using microarray gene-expression...

Detaylı Bibliyografya
Asıl Yazarlar:	Chan, C, Wong, N, Liu, Y, Bicknell, D, Turley, H, Hollins, L, Miller, C, Wilding, J, Bodmer, W
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
Yazar:: Bayrak Reyhan, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
Yazar:: Wong, N, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Human Homeobox TGIFLX Regulates CDX1, CDX2, and OCT1 Genes Expression in Colorectal Cancer Cell Lines
Yazar:: Soroosh Shahryarhesami, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

CDX1 is an important molecular mediator of Barrett's metaplasia.
Yazar:: Wong, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Cytokeratin 20-positive hepatocellular carcinoma
Yazar:: G. Faa, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01)

Cytokeratin 20-positive hepatocellular carcinoma
Yazar:: D. Fanni, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01)

Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma
Yazar:: Sabrina Bergeron, MSc, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Immunohistochemical Studies of Cytokeratins and Differentiation Markers in Bovine Ocular Squamous Cell Carcinoma
Yazar:: Helena Vala, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

p53 and cytokeratin 20 immune marker expression as dual marker in papillary lesions of urinary bladder
Yazar:: Anita P. Javalgi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
Yazar:: Jaudah Al-Maghrabi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Importance of cytokeratin-20 expression in papillary urothelial neoplasia
Yazar:: İbrahim Karabulut, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Cdx1 and Cdx2 exhibit transcriptional specificity in the intestine.
Yazar:: Stephanie Grainger, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining
Yazar:: Chaitra N, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.
Yazar:: Woodford-Richens, K, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers
Yazar:: Woodford-Richens, K, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer.
Yazar:: Chung-Chieh Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Significance of Tumour Budding with Case Series Cytokeratin 20 Immunostaining as a Histopathological Prognostic Marker in Colorectal Adenocarcinoma
Yazar:: Munireddy Swathi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
Yazar:: Tokumoto Noriaki, ve diğerleri
Baskı/Yayın Bilgisi: (2006-02-01)

Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
Yazar:: Twisha Adhikari, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

CDX2 Expression in ovarian teratomatous cells with intestinal differentiation
Yazar:: M. Mora, ve diğerleri
Baskı/Yayın Bilgisi: (2006-01-01)

Imaging features of mucinous carcinoma arising from mature teratoma showing cytokeratin 7+ and cytokeratin 20+ expression profile: A case report
Yazar:: Natsuko Atsukawa, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

The role of SATB2, CDX2, CK7 and CK20 in differentiating primary versus metastatic ovarian carcinoma
Yazar:: Sana Tahir, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Yazar:: Jain, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer
Yazar:: Ying-Ying Du, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Cytokeratins : advances in oncology /
Yazar:: Temple, Amy, editor
Baskı/Yayın Bilgisi: (2015)

GenCDX / [cakera padat]
Yazar:: 397147 Klug, William S., ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Cytokeratin 17: An Adjunct Immunohistochemical Marker of Invasion in Squamous Neoplastic Skin Lesions
Yazar:: Cem Leblebici
Baskı/Yayın Bilgisi: (2017-09-01)

Expression of cytokeratins 8 and 17 as a diagnostic marker of cervical intraepithelial neoplasia
Yazar:: Kalodimos George, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
Yazar:: Mariko Urano-Takaoka, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Selective activation of tumor growth-promoting Ca<sup>2+ </sup>channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
Yazar:: Huber Christoph, ve diğerleri
Baskı/Yayın Bilgisi: (2009-09-01)

The Importance of Cytokeratin 19 Expression in the Differentiation of Basal Cell Carcinoma and Trichoepithelioma
Yazar:: Recep Bedir, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines
Yazar:: Stephanie Holst, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression
Yazar:: Soyuer Serdar, ve diğerleri
Baskı/Yayın Bilgisi: (2009-06-01)

Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers.
Yazar:: Gilson, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Clinicopathological Evaluation of Gall-Bladder Lesions in Cholecystectomy Specimens with Special Emphasis to Incidentally Detected Cases of Gall-Bladder Carcinoma Along with Immunohistochemical Study of Cytokeratin 7 and Cytokeratin 20
Yazar:: Kakoli Bora, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Optimization of Cdx Transcription Factors Characteristics
Yazar:: Javanbakht T.
Baskı/Yayın Bilgisi: (2023-08-01)

Anti-cytokeratin 7: a positive marker for epithelial dysplasia in flat bowel mucosa
Yazar:: Svjetlana Radović, ve diğerleri
Baskı/Yayın Bilgisi: (2004-08-01)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
Yazar:: Fernando N. Aguiar, ve diğerleri
Baskı/Yayın Bilgisi: (2013-05-01)

Cdx2 regulates immune cell infiltration in the intestine
Yazar:: Simon Chewchuk, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
Yazar:: Dikshit Rajesh, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)